• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Premarket Brief On Trending Tickers: Amazon.com, Inc, DiDi Global, Solaredge, And More

    6/6/22 10:13:35 AM ET
    $AMZN
    $BABA
    $DIDI
    $JNJ
    Catalog/Specialty Distribution
    Consumer Discretionary
    Real Estate
    Real Estate
    Get the next $AMZN alert in real time by email

    Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.

    The data on the trending tickers is compiled from a list of most-discussed tickers on the popular Reddit forum WallStreetBets.

    Amazon.com, Inc (NASDAQ:AMZN) shares are up 1.93% during Monday’s morning session as the company’s 20–1 stock split is effective as of this June 6. Each share is around the $125 mark.

    Morgan Stanley analyst Brian Nowak maintained Amazon with an Overweight rating and adjusted the price target to $175.

    DiDi Global Inc - ADR (NYSE:DIDI) shares soared 55% on Monday morning following a report suggesting Chinese authorities will conclude a regulatory probe and lift a ban on new users for the company.

    Also Read: Why Nio Stock Could Soar 50% Higher If This Trend Continues

    Alibaba Group Holding Ltd - ADR (NYSE:BABA) shares are up almost 7% on Monday, trading in tandem with DiDi Global on the regulatory probe news.

    Novavax, Inc. (NASDAQ:NVAX) On Friday, shares plummeted as U.S. regulators expressed concerns about the company's anticipated Covid-19 vaccine. The FDA revealed some heart concerns with the shot, in documents released ahead of a conference with specialists on Tuesday, however, the agency remained upbeat about its effectiveness against the omicron variant and more severe disease.

    Yumanity Therapeutics Inc (NASDAQ:YMTX) Yumanity's stock soared more than 50% on Monday after the company announced that it had reached an agreement to sell its lead clinical-stage product candidate, YTX-7739, as well as discovery-stage neuroscience candidates to Janssen Pharmaceutical NV, a unit of Johnson & Johnson (NYSE:JNJ), for $26 million.

    Solaredge Technologies Inc (NASDAQ:SEDG) shares are trading 6.25% higher on Monday following news that President Biden will sign a proclamation permitting the import of solar panels from numerous countries without tariffs for 24 months

    Get the next $AMZN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMZN
    $BABA
    $DIDI
    $JNJ

    CompanyDatePrice TargetRatingAnalyst
    Amazon.com Inc.
    $AMZN
    4/24/2026$260.00 → $275.00Outperform
    Oppenheimer
    Amazon.com Inc.
    $AMZN
    4/20/2026$285.00 → $325.00Overweight
    KeyBanc Capital Markets
    Amazon.com Inc.
    $AMZN
    4/17/2026$280.00 → $285.00Buy
    Truist
    SolarEdge Technologies Inc.
    $SEDG
    4/15/2026$31.00Neutral → Sell
    Goldman
    Johnson & Johnson
    $JNJ
    4/8/2026$250.00Buy
    TD Cowen
    Amazon.com Inc.
    $AMZN
    4/7/2026$283.00 → $288.00Buy
    MoffettNathanson
    Amazon.com Inc.
    $AMZN
    3/25/2026$265.00 → $280.00Overweight
    Analyst
    Alibaba Group Holding Limited
    $BABA
    3/20/2026$135.00Buy → Hold
    DZ Bank
    More analyst ratings

    $AMZN
    $BABA
    $DIDI
    $JNJ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman of the Board Avery More bought $411,000 worth of shares (30,000 units at $13.70), increasing direct ownership by 12% to 274,478 units (SEC Form 4)

    4 - SOLAREDGE TECHNOLOGIES, INC. (0001419612) (Issuer)

    3/6/25 11:56:42 AM ET
    $SEDG
    Semiconductors
    Technology

    Director Weinberger Mark A bought $147,220 worth of shares (1,000 units at $147.22) (SEC Form 4)

    4 - JOHNSON & JOHNSON (0000200406) (Issuer)

    12/12/24 5:27:36 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Gani Marcel bought $228,648 worth of shares (20,000 units at $11.43), increasing direct ownership by 61% to 53,035 units (SEC Form 4)

    4 - SOLAREDGE TECHNOLOGIES, INC. (0001419612) (Issuer)

    11/14/24 4:01:07 PM ET
    $SEDG
    Semiconductors
    Technology

    $AMZN
    $BABA
    $DIDI
    $JNJ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oppenheimer reiterated coverage on Amazon with a new price target

    Oppenheimer reiterated coverage of Amazon with a rating of Outperform and set a new price target of $275.00 from $260.00 previously

    4/24/26 7:57:34 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    KeyBanc Capital Markets reiterated coverage on Amazon with a new price target

    KeyBanc Capital Markets reiterated coverage of Amazon with a rating of Overweight and set a new price target of $325.00 from $285.00 previously

    4/20/26 9:30:36 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Truist reiterated coverage on Amazon with a new price target

    Truist reiterated coverage of Amazon with a rating of Buy and set a new price target of $285.00 from $280.00 previously

    4/17/26 8:45:07 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    $BABA
    $DIDI
    $JNJ
    SEC Filings

    View All

    SEC Form DEFA14A filed by SolarEdge Technologies Inc.

    DEFA14A - SOLAREDGE TECHNOLOGIES, INC. (0001419612) (Filer)

    4/23/26 8:01:53 AM ET
    $SEDG
    Semiconductors
    Technology

    SEC Form DEF 14A filed by SolarEdge Technologies Inc.

    DEF 14A - SOLAREDGE TECHNOLOGIES, INC. (0001419612) (Filer)

    4/23/26 8:00:30 AM ET
    $SEDG
    Semiconductors
    Technology

    SEC Form 10-Q filed by Johnson & Johnson

    10-Q - JOHNSON & JOHNSON (0000200406) (Filer)

    4/22/26 4:02:41 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMZN
    $BABA
    $DIDI
    $JNJ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Jassy Andrew R

    4 - AMAZON COM INC (0001018724) (Issuer)

    4/21/26 4:51:10 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 4 filed by Walker Robert Edward

    4 - NOVAVAX INC (0001000694) (Issuer)

    4/16/26 6:13:00 PM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Herrington Douglas J

    4 - AMAZON COM INC (0001018724) (Issuer)

    4/16/26 6:12:32 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    $BABA
    $DIDI
    $JNJ
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AMZN
    $BABA
    $DIDI
    $JNJ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Meta Signs Agreement With AWS to Power Agentic AI on AWS Graviton Chips

    The deal helps power the agentic workloads behind Meta's AI efforts Key takeaways The deployment starts with tens of millions of Graviton cores, with the potential to expand. Meta is now one of the largest Graviton customers in the world. The deal builds on Meta's long-standing AWS relationship and use of Amazon Bedrock at scale to support its next generation of AI. Meta has signed an agreement to deploy AWS Graviton processors at scale. The deal marks a significant expansion of a long-standing partnership between the two companies as Meta builds its next generation of AI. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho

    4/24/26 8:10:00 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)

    Through 120 weeks of follow-up, IMAAVY delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including anti-AChR+ and anti-MuSK+Patients achieving sustained minimal symptom expression (MSE) experienced greater improvements in quality of life than those with transient MSE in a post-hoc analysis of the Phase 3 studyEPIC, the first head-to-head study of IMAAVY versus another FcRn blocker in generalized myasthenia gravis, is now enrolling participantsHORSHAM, Pa., April 22, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced new data from the Phase 3 Vivacity-MG3 study and ongoing open label extension (OLE) in a broad population o

    4/22/26 8:05:00 AM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Johnson & Johnson to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

    Johnson & Johnson (NYSE:JNJ) will participate in the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19th. Management will participate in a Fireside Chat at 11:30 a.m. Eastern Time. This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com. The audio webcast replay will be available approximately 48 hours after the webcast. View source version on businesswire.com: https://www.businesswire.com/news/home/20260421719308/en/ Media contact: [email protected] Investor contact: [email protected]

    4/21/26 4:22:00 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMZN
    $BABA
    $DIDI
    $JNJ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by SolarEdge Technologies Inc.

    SC 13G/A - SOLAREDGE TECHNOLOGIES, INC. (0001419612) (Subject)

    11/14/24 4:38:03 PM ET
    $SEDG
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by Alibaba Group Holding Limited

    SC 13G/A - Alibaba Group Holding Ltd (0001577552) (Filed by)

    11/14/24 4:03:02 PM ET
    $BABA
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Alibaba Group Holding Limited

    SC 13G/A - Alibaba Group Holding Ltd (0001577552) (Subject)

    11/14/24 6:01:51 AM ET
    $BABA
    Real Estate

    $AMZN
    $BABA
    $DIDI
    $JNJ
    Financials

    Live finance-specific insights

    View All

    Amazon.com to Webcast First Quarter 2026 Financial Results Conference Call

    Amazon.com, Inc. (NASDAQ:AMZN) announced today that it will hold a conference call to discuss its first quarter 2026 financial results on Wednesday, April 29, 2026, at 2:30 p.m. PT/5:30 p.m. ET. The event will be webcast live, and the audio and associated slides will be available for at least three months thereafter at www.amazon.com/ir. View source version on businesswire.com: https://www.businesswire.com/news/home/20260415758081/en/ Amazon.com Public Relations [email protected] amazon.com/ir

    4/15/26 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amazon to Acquire Globalstar and Expand Amazon Leo Satellite Network

    Globalstar satellites, radio frequency spectrum, and operational expertise will enable Amazon Leo to add Direct-to-Device (D2D) services to future generations of its low Earth orbit satellite network New Amazon Leo D2D system will help mobile network operators extend voice, text, and data services to customers beyond the reach of terrestrial cellular networks Amazon and Apple enter agreement for Amazon Leo to power satellite services for supported iPhone and Apple Watch models, allowing users to text emergency services, message friends and family, request roadside assistance, and more Today Amazon.com, Inc. (NASDAQ:AMZN) and Globalstar, Inc. (NASDAQ:GSAT) announced that they have ente

    4/14/26 8:00:00 AM ET
    $AMZN
    $GSAT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Telecommunications Equipment

    Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%

    Johnson & Johnson (NYSE:JNJ) today announced that its Board of Directors has declared a 3.1% increase in the quarterly dividend, from $1.30 per share to $1.34 per share, marking the 64th year of consecutive increases. At the new rate, the indicated dividend on an annual basis is $5.36 per share compared to the previous rate of $5.20 per share. The next quarterly dividend is payable on June 9, 2026 to shareholders of record at the close of business on May 26, 2026. The ex-dividend date is May 26, 2026. About Johnson & Johnson At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, tr

    4/14/26 6:21:00 AM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMZN
    $BABA
    $DIDI
    $JNJ
    Leadership Updates

    Live Leadership Updates

    View All

    Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

    Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical OfficerDr. Walker will continue advancing Novavax's R&D efforts with a focus on data generation to facilitate partnering discussions, Matrix adjuvant innovation and advancement of the Company pipeline  GAITHERSBURG, Md., March 30, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development (R&D). Dr. Walker now reports to John C. Jacobs, President and Chief Executive Officer of Novavax.A specialist in internal medicine and pulmonary and critical care medi

    3/30/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    The $17 Billion Solar Maintenance Market Just Got a New Player From the Defense Sector

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this article: VisionWave Holdings (NASDAQ:VWAV), First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SunPower (NASDAQ:SPWR), SolarEdge Technologies (NASDAQ:SEDG) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) subsidiary SolarDrone has acquired a 51% controlling interest in Junko Solar, an Israeli solar panel maintenance and cleaning company, and appointed its founder Amos Cohen as SolarDrone CEO.The global solar panel operation and maintenance market is valued at $17 billion in 2026 and projected to reach nearly $60 billion by 2035, growing at a 13.3% CAGR[1].First Solar inaugurated a $1.1 billion AI-enabled manuf

    3/17/26 9:00:00 AM ET
    $ENPH
    $FSLR
    $SEDG
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    SolarEdge Announces Departure of CFO

    Asaf Alperovitz to Depart the Company in June; Company Re-affirms Its Financial Guidance for the First Quarter SolarEdge Technologies, Inc. ("SolarEdge" or the "Company") (NASDAQ:SEDG), a global leader in smart energy technology, announced today that Chief Financial Officer Asaf Alperovitz has notified the Board of Directors of his decision to step down to pursue a chief financial officer role at a public company outside of the industry. The Board of Directors is initiating a process to identify a replacement CFO. Mr. Alperovitz will continue to serve as the Company's Chief Financial Officer through June 9, 2026, to support its ongoing operations and the leadership transition. Shuki

    3/10/26 5:01:00 PM ET
    $SEDG
    Semiconductors
    Technology